NUP98 is fused to HOXA9 in a variant complex t(7;11;13;17) in a patient with AML-M2

The t(7;11)(p15;p15.4) has been reported to fuse the NUP98 gene (11p15), a component of the nuclear pore complex, with the class-1 homeobox gene HOXA9 at 7p15. This translocation has been associated with myeloid leukemias, predominantly acute myeloid leukemia (AML) M2 subtype with trilineage myelody...

Full description

Saved in:
Bibliographic Details
Published inCancer genetics and cytogenetics Vol. 157; no. 2; pp. 151 - 156
Main Authors Lahortiga, Idoya, Belloni, Elena, Vázquez, Iria, Agirre, Xabier, Larrayoz, María J., Vizmanos, Jose L., Valgañón, Mikel, Zudaire, Isabel, Sáez, Borja, Mateos, María C., Di Fiore, Pier Paolo, Calasanz, María J., Odero, María D.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.03.2005
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The t(7;11)(p15;p15.4) has been reported to fuse the NUP98 gene (11p15), a component of the nuclear pore complex, with the class-1 homeobox gene HOXA9 at 7p15. This translocation has been associated with myeloid leukemias, predominantly acute myeloid leukemia (AML) M2 subtype with trilineage myelodysplastic features, and with a poor prognosis. The derived fusion protein retains the FG repeat motif of NUP98 N-terminus and the homeodomain shared by the HOX genes, acting as an oncogenic transcription factor critical for leukemogenesis. We report here a new complex t(7;11)-variant, i.e., t(7;11;13;17)(p15;p15;p?;p1?2) in a patient with AML-M2 and poor prognosis. The NUP98-HOXA9 fusion transcript was detected by RT-PCR, suggesting its role in the malignant transformation as it has been postulated for other t(7;11)-associated leukemias. No other fusion transcripts involving the NUP98 or HOXA9 genes were present, although other mechanisms involving several genes on chromosomes 13 and 17 may also be involved. To our knowledge, this is the first t(7;11) variant involving NUP98 described in hematological malignancies.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Case Study-2
ObjectType-Feature-4
ObjectType-Report-1
ObjectType-Article-3
ISSN:0165-4608
1873-4456
DOI:10.1016/j.cancergencyto.2004.08.001